Clinical Trials in Houston

Showing 5881-5900 of 13,620 trials

Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

NCT03904069

Evaluate the safety and tolerability of AMG 553 in adult and adolescent subjects with FLT3-positive R/R AML. Determine the maximum tolerated cell dose (MTCD) or recommended phase 2 cell dose (RP2CD) of AMG 553.

Relapsed/Refractory Acute Myeloid Leukemia

AmgenStarted Mar 2023

Duarte, California, United States • Palo Alto, California, United States • Houston, Texas, United States

TERMINATEDPhase 2< 1 mile

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

NCT03397394

The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.

Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+5 more

pharmaand GmbH97 participantsStarted Jun 2018

Scottsdale, Arizona, United States • La Jolla, California, United States • Los Angeles, California, United States +61 more locations

Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Find Trials by Condition in Houston

PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis

Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma

LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis

International Hernia Mesh Registry

Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)

Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.

A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer

An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies